27 jul: Spanien/IMF: Fortsatte reformer altafgørende i sort situation
30 jul: Kalender - mandag den 30 juli
27-07-2012 20:36:00

MARKET SNAPSHOT: U.S. Stocks Rally, Dow Tops 13,000

Relateret indhold

By Kate Gibson, MarketWatch

NEW YORK (MarketWatch) -- U.S. stocks rallied on Friday, reclaiming weekly gains and pushing the Dow Jones Industrial Average to a nearly three-month high, as investors anticipated central-bank moves in Europe as well as by the U.S. Federal Reserve.

Stocks hit session highs after Bloomberg News reported European Central Bank President Mario Draghi would hold talks with Bundesbank President Jens Weidmann in an attempt to remove the biggest obstacles to adopting new measures including bond purchases.

"Between Draghi's comments and the GDP numbers today, we're bid up on prospects of monetary intervention," said Mark Luschini, chief investment strategist at Janney Montgomery Scott.

After a 229-point rise, the Dow Jones Industrial Average (DJI) was lately up 179.25 points, or 1.4%, to 13,065.89, its first intraday rise above 13,000 since May 8.

Merck & Co. Inc. (MRK) led the gains that included all but three of its 30 components.

Merck shares rallied 3.8% after the pharmaceutical company's earnings topped forecasts.

The S&P 500 index (SPX) added 23.03 points, or 1.7%, to 1,383.05, with health care and industrials the best performing of its 10 major industry sectors.

Amgen Inc. (AMGN) gained 4.7% after the biotechnology company raised its 2012 outlook and reported second-quarter profit that exceeded analysts' estimates.

The Nasdaq Composite (RIXF) gained 55.48 points, or 1.9%, to 2,948.71.

Facebook Inc. (FB) shares slid 12% after the social-networking site offered little reassurance to investors concerned about its lofty valuation.

For every stock declining, five gained on the New York Stock Exchange, where 491 million shares were exchanged as of 2:30 p.m. Eastern.

Global equities gained after German Chancellor Angela Merkel and French President Francois Hollande said they were committed to keeping the euro area together. French newspaper Le Monde reported the European Central Bank was readying to purchase debt.

The major stock indexes held gains after a gauge of consumer sentiment came in just above expectations, as did a separate report on U.S. economic growth in the second quarter. .

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 27, 2012 14:36 ET (18:36 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

DSV/Nykredit: Kursmål bliver hævet med 8 pct. før regnskab

28-04-2017 14:21:41
Nykredit hæver kursmålet for DSV-aktien til 400 kr. fra 370 kr. forud for transportkoncernens regnskab i næste uge.Banken vurderer, at DSV står stærkt på markedet og kan begynde at fokusere på organisk vækst, efter at det seneste år primært er gået med at integrere amerikanske UTI Worldwide, der blev købt sidste år for 9,5 mia. kr.- Vi har hævet vores estimater for de kommende år. Derudover har vi..

Novo/Nordea: Sanofi-regnskab indikerer lyspunkt på vækstmarkeder

28-04-2017 11:31:07
Kvartalsregnskabet fra Novo Nordisks store franske rival, Sanofi, vidner om, at diabetesforretningen har haft en en stærk udvikling på vækstmarkederne, mens salget er under pres i USA.Og det er en tendens, som Nordea regner med også kan slå igennem i Novos regnskabstal på onsdag. Det fremgår af et notat.Nordea understreger dog, at det langt fra er ligetil at drage paralleller fra Sanofis regnskab...

Novo-rival slår overskuds- og salgsforventninger i første kvartal - NY

28-04-2017 08:06:11
Den franske medicinalvirksomhed Sanofi, der er blandt Novo Nordisks største konkurrenter, er kommet ud af årets første tre måneder med en bedre indtjening end ventet.I første kvartal endte det justerede overskud per aktie (Business EPS, red.) på 1,42 euro, hvilket var højere end de 1,26 euro, som analytikerne ifølge Bloomberg News havde sat næsen op efter.Den samlede omsætning steg til 8,65 mia. e..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Merck & Company Inc (ne 62,33 -0,4% Fald i aktiekurs
Amgen Inc 163,32 0,4% Stigning i aktiekurs
Merck AND CO Inc 56,96 -0,3% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. april 2017 14:50:01
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB7 - 2017-04-30 14:50:01 - 2017-04-30 14:50:01 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x